In poor prognosis acute myeloid leukemia (AML) patients, NK cell infusions in combination with high dose chemotherapy and IL2 infusion resulted in in vivo expansion of NK cells and complete hematologic remission in 5 out of 19 patients (102). Here, IL2 is linked to acute myeloid leukemia.